The Therapeutic Goods Administration (TGA) has granted provisional determination to Pfizer’s COVID-19 vaccine, Comirnaty™ as part of an application process to lower the approved age limit of vaccine administration from 16 years and above, to individuals aged 12 years and above.

Provisional determination is the first step in the provisional registration pathway. The provisional pathway for registration provides a formal and transparent mechanism for speeding up the registration of promising new medicines based on preliminary clinical data. Having provisional determination does not mean that provisional registration will be granted.

要阅读更多信息,请点击以下链接:

Provisional determination granted to Pfizer in relation to COVID 19 vaccine, COMIRNATY – for use in individuals 12 years of age and older

MVEC acknowledges the traditional owners of the lands on which we live, work and educate. We pay our respects to their Elders, past, present and emerging.
We are committed to honouring Australian Aboriginal and Torres Strait Islander peoples’ unique cultural and spiritual relationships to the land, waters and seas.

关于 MVEC

墨尔本疫苗教育中心 (MVEC) 是一个教育网站,旨在为医疗保健专业人员和公众提供最新的免疫接种信息。我们位于研究机构默多克儿童研究所 (MCRI),隶属于维多利亚疫苗安全服务机构 SAEFVIC(社区接种疫苗后的不良事件监测)。

分享这个